Table 1.
Trial start year | No. of new US cancer patients* | Planned US trial enrollment†/No. of new cancer patients (%) |
||
NCI-sponsored trials | Other-sponsored trials | Total | ||
2005 | 1 349 922 | 2.90 | 3.24 | 6.14 |
2006 | 1 375 718 | 2.81 | 3.84 | 6.65 |
2007 | 1 406 840 | 2.02 | 4.14 | 6.16 |
2008 | 1 437 373 | 1.81 | 3.73 | 5.54 |
2009 | 1 464 339 | 1.79 | 4.62 | 6.41 |
2005–2009 | 7 034 192 | 2.25‡ | 3.92‡ | 6.18‡ |
Based on US Census population data and cancer incidence estimates from the Surveillance, Epidemiology, and End Results Program.
From ClinicalTrials.gov.
Percentages for the combined years 2005–2009 given as weighted averages of the annual percentages in the cells above.